It is hard to believe that spring is finally here and the Food and Drug Administration’s (“FDA”) Office of Prescription Drug Promotion (“OPDP”) has yet to take any enforcement action in 2023. While this seems unusual, it appears consistent with the OPDP’s seemingly measured approach to enforcement actions in recent years. It may also... READ MORE
A Look Back at the Office of Prescription Drug Promotion Enforcement in 2022 and Lessons for 2023
Posted on March 29, 2023 in Health Law News
Published by: Hall Render
